Sea Lane Biotechnologies - Antibody and Protein Engineering Technology's Unit Acquisition

Sea Lane Biotechnologies - Antibody and Protein Engineering Technology raised a round of funding on May 30, 2017. Investors include i2 Pharmaceuticals.

The Sea Lane Biotechnologies fully human bio-therapeutic platform technologies provide unique solutions for pressing therapeutic needs. The company's technologies and inventions include the unique the…

Articles about Sea Lane Biotechnologies - Antibody and Protein Engineering Technology's Unit Acquisition: